framycetin has been researched along with tamoxifen in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Arya, DP; Degtyareva, NN; Garneau-Tsodikova, S; Green, KD; Khodaverdian, V; Maiti, K; Oyelere, AK; Skriba, MJ; Story, S | 1 |
| Morley, P; Schwartz, JL; Tsang, BK; Vanderhyden, BC; Whitfield, JF | 1 |
| Fraunfelder, FT | 1 |
| Bayard, F; Delarue, F; Faye, JC; Mesange, F; Puel, J | 1 |
| Chen, YZ; Ung, CY | 1 |
9 other study(ies) available for framycetin and tamoxifen
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Synthesis, antimicrobial activity, attenuation of aminoglycoside resistance in MRSA, and ribosomal A-site binding of pyrene-neomycin conjugates.
Topics: Aminoglycosides; Animals; Binding Sites; Drug Resistance, Bacterial; Framycetin; Gram-Positive Bacteria; Humans; Methicillin-Resistant Staphylococcus aureus; Protein Binding; Pyrenes; Ribosomal Proteins; Staphylococcal Infections | 2019 |
A new, nongenomic estrogen action: the rapid release of intracellular calcium.
Topics: Androgens; Animals; Calcium; Cells, Cultured; Chickens; Cycloheximide; Dactinomycin; Egtazic Acid; Estrenes; Estrogens; Female; Granulosa Cells; Kinetics; Lanthanum; Neomycin; Progestins; Pyrrolidinones; Rats; Rats, Inbred Strains; Swine; Tamoxifen; Time Factors; Transcription, Genetic; Type C Phospholipases | 1992 |
Interim report: National Registry of possible Drug-induced Ocular Side Effects.
Topics: Contact Lenses; Drug-Related Side Effects and Adverse Reactions; Eye Diseases; Fluorouracil; Humans; Ibuprofen; Methotrexate; Neomycin; Practolol; Registries; Sterilization; Tamoxifen; Timolol; United States; United States Food and Drug Administration | 1980 |
Ligands of the antiestrogen-binding site are able to inhibit virion production of human immunodeficiency virus 1-infected lymphocytes.
Topics: Antiviral Agents; Binding Sites; Cells, Cultured; Estrogen Antagonists; Ethanol; HIV Core Protein p24; HIV-1; Humans; Interleukin-2; Kinetics; Ligands; Lymphocyte Activation; Lymphocytes; Neomycin; Receptors, Drug; Tamoxifen; Virion; Virus Replication; Zidovudine | 1996 |
Prediction of potential toxicity and side effect protein targets of a small molecule by a ligand-protein inverse docking approach.
Topics: Ascorbic Acid; Aspirin; Computer Simulation; Drug-Related Side Effects and Adverse Reactions; Gentamicins; Ibuprofen; Indinavir; Ligands; Models, Molecular; Molecular Structure; Neomycin; Penicillin G; Pharmaceutical Preparations; Proteins; Software; Tamoxifen | 2001 |